(Q34145800)

31 July 2017

1 reference

title

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations (English)

1 reference

31 July 2017

1 reference

1 reference

Caligiuri MR

1

1 reference

31 July 2017

Jeste DV

series ordinal

2

1 reference

31 July 2017

Lacro JP

series ordinal

3

1 reference

31 July 2017

publication date

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

363-384

1 reference

Gender differences in tardive dyskinesia: a critical review of the literature

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200017050-00004

Tardive dyskinesia and anticholinergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200017050-00004

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200017050-00004

Clozapine in Older Patients With Psychosis and Behavioral Disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200017050-00004

Conventional vs. newer antipsychotics in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200017050-00004

Treatment of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200017050-00004

Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200017050-00004

Propranolol in the treatment of neuroleptic-induced akathisia (NIA) in schizophrenics: a double-blind, placebo-controlled study

21 January 2018

1 reference

12 December 2020

Extrapyramidal motor signs in clinically diagnosed Alzheimer disease.

1 reference

12 December 2020

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

1 reference

12 December 2020

Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal

1 reference

12 December 2020

Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients

1 reference

12 December 2020

Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

1 reference

12 December 2020

Quantitative assessment of psychomotor activity in patients with neuroleptic-induced akathisia

1 reference

12 December 2020

Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone

1 reference

12 December 2020

Pathophysiologic basis for schizophrenia and the efficacy of antipsychotics

1 reference

12 December 2020

Dopamine receptor agonist- and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisms of acute oral dyskinesia

1 reference

12 December 2020

Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?

1 reference

12 December 2020

Botulinum toxin in the treatment of tardive dystonia

1 reference

12 December 2020

Prospective study of tardive dyskinesia incidence in the elderly

1 reference

12 December 2020

A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical Setting

1 reference

12 December 2020

Prospective study of tardive dyskinesia in the elderly: rates and risk factors

1 reference

12 December 2020

Managing antipsychotic-induced acute and tardive dystonia

1 reference

12 December 2020

Neuroleptics and the Elderly

1 reference

12 December 2020

Drug sensitivity in older adults: the role of physiologic and pharmacokinetic factors

1 reference

12 December 2020

Clozapine is beneficial for psychosis in Parkinson's disease

1 reference

12 December 2020

Asymmetry of neuroleptic-induced rigidity: development of quantitative methods and clinical correlates

1 reference

12 December 2020

Movement disorders associated with the serotonin selective reuptake inhibitors

1 reference

12 December 2020

Neuroleptic-induced parkinsonism in older schizophrenics

1 reference

12 December 2020

Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia

1 reference

12 December 2020

Plasma level monitoring of antipsychotic drugs. Clinical utility

1 reference

12 December 2020

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

12 December 2020

Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis.

1 reference

12 December 2020

γ-Acetylenic GABA in Tardive Dyskinesia

1 reference

12 December 2020

Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia

1 reference

12 December 2020

Treatment of facial and orolinguomandibular tardive dystonia by botulinum toxin A: evidence of a long-lasting effect

1 reference

12 December 2020

Incidence of tardive dyskinesia: five-year data from a prospective study

1 reference

12 December 2020

Serotonin-dopamine interaction and its relevance to schizophrenia

1 reference

12 December 2020

Akathisia variants and tardive dyskinesia

1 reference

12 December 2020

Drug-induced parkinsonism in the elderly

1 reference

12 December 2020

Relationship between diazepam dose, plasma level, age, and central nervous system depression

1 reference

12 December 2020

Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy

1 reference

12 December 2020

Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism

1 reference

12 December 2020

Clozapine in elderly psychiatric patients: tolerability, safety, and efficacy

1 reference

12 December 2020

Long-term treatment effects of vitamin E for tardive dyskinesia

1 reference

12 December 2020

Successful propranolol therapy for neuroleptic-induced akathisia resistant to anticholinergic and benzodiazepine drugs

1 reference

12 December 2020

Efficacy of propranolol in neuroleptic-induced akathesia

1 reference

12 December 2020

Tardive akathisia: an analysis of clinical features and response to open therapeutic trials

1 reference

12 December 2020

Prevalence of spontaneous dyskinesia in schizophrenia.

1 reference

12 December 2020

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol

1 reference

12 December 2020

Polypharmacy in the elderly: a fait accompli?

1 reference

12 December 2020

Adverse neurobiological effects of long-term use of neuroleptics: human and animal studies

1 reference

12 December 2020

Neuroleptic-induced akathisia: a review

1 reference

12 December 2020

Drug Therapy in the Elderly

1 reference

12 December 2020

Tardive dyskinesia: prevalence, incidence, and risk factors

1 reference

12 December 2020

Natural history and treatment of tardive dystonia.

1 reference

12 December 2020

Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.

1 reference

12 December 2020

Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol in the treatment of neuroleptic-induced akathisia

1 reference

12 December 2020

AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION

1 reference

12 December 2020

Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group.

1 reference

12 December 2020

Should risperidone be used in Parkinson's disease?

1 reference

12 December 2020

Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.

1 reference

12 December 2020

Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on biological aspects of mental illness

1 reference

12 December 2020

Beta-blockers and depression: the more the murkier?

1 reference

12 December 2020

A review of 32 cases of tardive dystonia

1 reference

12 December 2020

Metoclopramide and tardive dyskinesia.

1 reference

12 December 2020

Pharmacokinetic factors affecting antidepressant drug clearance and clinical effect: evaluation of doxepin and imipramine--new data and review

1 reference

12 December 2020

Metabolism of thioridazine in the elderly

1 reference

12 December 2020

Akathisia, pseudoakathisia and tardive dyskinesia: Clinical examples

1 reference

12 December 2020

Drug-induced movement disorders

1 reference

12 December 2020

An open-label study of botulinum toxin A for treatment of tardive dystonia

1 reference

12 December 2020

Metoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus. Two case reports

1 reference

12 December 2020

Tardive dyskinesia: a review and current treatment options.

1 reference

12 December 2020

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

12 December 2020

A comparison of severe tardive dystonia and severe tardive dyskinesia

1 reference

12 December 2020

Motor disorders induced by neuroleptics: a proposed new classification.

1 reference

12 December 2020

Acute dystonia induced by drug treatment

1 reference

12 December 2020

Acute extrapyramidal side effects: Serum levels of neuroleptics and anticholinergics

1 reference

12 December 2020

Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders.

1 reference

12 December 2020

Clozapine use in female geriatric patients with psychoses

1 reference

12 December 2020

Guidelines for prescribing psychoactive drugs in the elderly: Part 1

1 reference

12 December 2020

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs

1 reference

12 December 2020

Ethnicity and psychopharmacology

1 reference

12 December 2020

Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs

1 reference

12 December 2020

Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group

1 reference

12 December 2020

Clozapine prevents recurrence of psychosis in Parkinson's disease

1 reference

12 December 2020

The effect of aging on rat striatal D1 receptor mRNA-containing neurons.

1 reference

12 December 2020

Problems in the treatment of Parkinsonism

1 reference

12 December 2020

Propranolol in the treatment of neuroleptic-induced akathisia

1 reference

12 December 2020

A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia

1 reference

12 December 2020

What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group

1 reference

12 December 2020

Receptor pharmacology of neuroleptics: relation to clinical effects

1 reference

12 December 2020

Vitamin E treatment of tardive dyskinesia

1 reference

12 December 2020

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

1 reference

12 December 2020

The long-term treatment of schizophrenia

1 reference

12 December 2020

Treatment of akathisia with lorazepam. An open clinical trial

1 reference

12 December 2020

Improvement in Tardive Dyskinesia After Muscimol Therapy

1 reference

12 December 2020

The incidence of depression in new users of beta-blockers and selected antihypertensives

1 reference

12 December 2020

The pharmacologic treatment of neuroleptic-induced akathisia.

1 reference

12 December 2020

Prevalence of dystonia in veterans on chronic antipsychotic therapy

1 reference

12 December 2020

Gradual withdrawal of long-term anticholinergic antiparkinson medication in Chinese patients with chronic schizophrenia.

1 reference

12 December 2020

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

12 December 2020

Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics

1 reference

12 December 2020

Extrapyramidal disorders after prolonged phenothiazine therapy

1 reference

12 December 2020

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

1 reference

12 December 2020

Low-dose mianserin in treatment of acute neuroleptic-induced akathisia

1 reference

12 December 2020

Factors in the development of severe forms of tardive dyskinesia

1 reference

12 December 2020

A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis.

1 reference

12 December 2020

Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects

1 reference

12 December 2020

Managing antipsychotic-induced parkinsonism

1 reference

12 December 2020

Early detection of neuroleptic-induced parkinsonism in elderly patients with dementia

1 reference

12 December 2020

New atypical antipsychotic medications

1 reference

12 December 2020

The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias.

1 reference

12 December 2020

Clozapine efficacy in tardive dyskinesia in schizophrenic patients

1 reference

12 December 2020

Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study

1 reference

12 December 2020

A survey of drug-induced extrapyramidal reactions

1 reference

12 December 2020

Decreased beta-adrenergic responsiveness during senescence

1 reference

12 December 2020

Use of clonazepam in an elderly bipolar patient with tardive dyskinesia: a case report

1 reference

12 December 2020

Psychotropic blood levels: a guide to clinical response.

1 reference

12 December 2020

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

1 reference

12 December 2020

Risperidone-induced tardive dyskinesia

1 reference

12 December 2020

Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A

1 reference

12 December 2020

Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients

1 reference

12 December 2020

Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study

1 reference

12 December 2020

Cyproheptadine treatment in neuroleptic-induced akathisia.

1 reference

12 December 2020

Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication

1 reference

12 December 2020

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

1 reference

12 December 2020

Improving documentation of consent for neuroleptic therapy.

1 reference

12 December 2020

Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients

1 reference

12 December 2020

1 reference

12 December 2020

Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging.

1 reference

12 December 2020

Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia

1 reference

12 December 2020

Antipsychotics from theory to practice: integrating clinical and basic data

1 reference

12 December 2020

Relationship of neuroleptic-induced akathisia to drug-induced parkinsonism

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades

1 reference

12 December 2020

Research Diagnoses for Tardive Dyskinesia

1 reference

12 December 2020

Coarse, jerky foot tremor: Tremographic investigation of an objective sign of acute akathisia

1 reference

12 December 2020

Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease

1 reference

12 December 2020

Tardive dyskinesia in elderly psychiatric patients: a 5-year study

1 reference

12 December 2020

Agranulocytosis: incidence and risk factors

1 reference

12 December 2020

Tardive dyskinesia in India: a prevalence study

1 reference

12 December 2020

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

1 reference

12 December 2020

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

12 December 2020

Tardive dyskinesia in elderly psychiatric patients in Singapore

1 reference

12 December 2020

Neurologic approach to drug-induced movement disorders: a study of 125 patients

1 reference

12 December 2020

Marked reduction of tardive dyskinesia with olanzapine

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

Pharmacological options for the management of dyskinesias

1 reference

12 December 2020

New atypical antipsychotics. Experience and utility in the elderly

1 reference

12 December 2020

Risperidone-induced tardive dyskinesia and parkinsonism

1 reference

12 December 2020

Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses

1 reference

12 December 2020

Tardive dyskinesia, clozapine, and treatment response

1 reference

12 December 2020

Vitamin E in the treatment of tardive dyskinesia

1 reference

12 December 2020

Alpha-tocopherol in tardive dyskinesia

1 reference

12 December 2020

Clonazepam treatment of adolescents with neuroleptic-induced akathisia

1 reference

12 December 2020

Prolonged drug-induced Parkinsonism

1 reference

12 December 2020

Pharmacokinetics in the aged: A review

1 reference

12 December 2020

GABA agonist-induced changes in motor, oculomotor, and attention measures correlate in schizophrenics with tardive dyskinesia

1 reference

12 December 2020

Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction

1 reference

12 December 2020

10.2165/00002512-200017050-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1053314718

0 references

1 reference